Is The Universal Turing Machine a Capitalist Super-Machine?
Technophany, A Journal for Philosophy and Technology · 13.05.2026 · 1-23
DOI: 10.54195/technophany.21958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technophany, A Journal for Philosophy and Technology, online erschienen am 13.05.2026. Verfasst von Bo Kampmann Walther. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper explores the hypothesis that capitalism might be understood as a computational phenomenon, akin to a program running on a Universal Turing Machine (UTM). Grounded in the principles of digital physics, Marxist theory, and techno-criticism, it proposes that if the universe is fundamentally computable, then socio-economic systems like capitalism could also be seen as outputs of this universal computational process, thus questioning whether capitalism emerges as a neutral outcome or as an inevitable consequence of its design. Drawing from philosophical and political critiques, the paper interrogates the implications of this hypothesis for human agency, resistance, and the construction of alternative social frameworks. The film Cube is used as a fictional case study to illustrate the dynamics of interacting with a capitalist super-machine. Furthermore, the paper reflects on quantum computing's impact on the UTM hypothesis.
Zitieren
APA
Walther, B. K. (2026). Is The Universal Turing Machine a Capitalist Super-Machine?. Technophany, A Journal for Philosophy and Technology, 1-23. https://doi.org/10.54195/technophany.21958
Vancouver
Walther BK. Is The Universal Turing Machine a Capitalist Super-Machine?. Technophany, A Journal for Philosophy and Technology. 2026:1-23. doi:10.54195/technophany.21958
BibTeX
@article{Walther2026,
author = {Walther, Bo Kampmann},
title = {Is The Universal Turing Machine a Capitalist Super-Machine?},
journal = {Technophany, A Journal for Philosophy and Technology},
year = {2026},
pages = {1--23},
doi = {10.54195/technophany.21958}
}
EUVIMED